Contributed By Walder Wyss Ltd
The marketing authorisation-holder must designate a person who is responsible for the advertising of the medicines that they have placed on the market. This person must have scientific, medical or other appropriate professional training or experience. This person must ensure that the advertising of medicines complies with the according provisions and that Swissmedic’s instructions are complied with immediately and in full. Furthermore, this person must provide Swissmedic with all the required documents and information upon request and ensure that its pharmaceutical representatives are properly trained and comply with the obligations stated in the AWV. Finally, this person must keep a copy of each distributed advertisement for six months after its last intended use as well as a register of all recipients, the method of distribution and the date of first distribution (Article 25 AWV).
The Pharma Code further states that pharmaceutical companies must set up a scientific service that is responsible for the information about their medicines and their promotion to healthcare professionals. The scientific service includes a doctor or, if suitable, a pharmacist or scientist who is responsible for ensuring the conformity of all promotional and information materials with the Pharma Code before they are deployed (rule 53 Pharma Code).